Jpmorgan Chase & CO Medpace Holdings, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.27 Trillion
  • Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 147,969 shares of MEDP stock, worth $78 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
147,969
Previous 147,166 0.55%
Holding current value
$78 Million
Previous $48.9 Million 7.79%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
BUY
$304.69 - $360.97 $244,666 - $289,858
803 Added 0.55%
147,969 $45.1 Million
Q4 2024

Feb 12, 2025
SELL
$308.93 - $363.58 $8.67 Million - $10.2 Million
-28,073 Reduced 16.02%
147,166 $48.9 Million
Q3 2024

Dec 26, 2024
BUY
$320.58 - $457.29 $3.99 Million - $5.7 Million
12,455 Added 7.65%
175,239 $58.4 Million
Q3 2024

Nov 08, 2024
BUY
$320.58 - $457.29 $3.99 Million - $5.7 Million
12,455 Added 7.65%
175,239 $58.4 Million
Q2 2024

Dec 26, 2024
SELL
$372.0 - $424.34 $4.63 Million - $5.29 Million
-12,455 Reduced 7.11%
162,784 $67 Million
Q2 2024

Aug 12, 2024
SELL
$372.0 - $424.34 $4.06 Million - $4.63 Million
-10,901 Reduced 6.28%
162,784 $67 Million
Q1 2024

Dec 26, 2024
SELL
$284.87 - $413.31 $442,687 - $642,283
-1,554 Reduced 0.89%
173,685 $70.2 Million
Q1 2024

May 10, 2024
BUY
$284.87 - $413.31 $3.92 Million - $5.69 Million
13,767 Added 8.61%
173,685 $70.2 Million
Q4 2023

Dec 26, 2024
SELL
$227.52 - $312.68 $3.49 Million - $4.79 Million
-15,321 Reduced 8.74%
159,918 $49 Million
Q4 2023

Feb 12, 2024
BUY
$227.52 - $312.68 $8.72 Million - $12 Million
38,334 Added 31.53%
159,918 $49 Million
Q3 2023

Nov 14, 2023
SELL
$233.98 - $281.67 $999,796 - $1.2 Million
-4,273 Reduced 3.4%
121,584 $29.4 Million
Q2 2023

Aug 11, 2023
BUY
$187.26 - $240.17 $2.81 Million - $3.6 Million
14,987 Added 13.52%
125,857 $30.2 Million
Q1 2023

May 18, 2023
BUY
$174.31 - $239.52 $10.9 Million - $15 Million
62,716 Added 130.24%
110,870 $20.8 Million
Q1 2023

May 11, 2023
SELL
$174.31 - $239.52 $9.1 Million - $12.5 Million
-52,198 Reduced 52.01%
48,154 $9.06 Million
Q4 2022

Feb 13, 2023
SELL
$153.06 - $226.57 $719,688 - $1.07 Million
-4,702 Reduced 4.48%
100,352 $21.3 Million
Q3 2022

Nov 14, 2022
SELL
$145.13 - $182.49 $737,260 - $927,049
-5,080 Reduced 4.61%
105,054 $16.5 Million
Q2 2022

Aug 11, 2022
SELL
$130.2 - $168.03 $999,154 - $1.29 Million
-7,674 Reduced 6.51%
110,134 $16.5 Million
Q1 2022

May 11, 2022
BUY
$138.87 - $214.31 $1.48 Million - $2.28 Million
10,632 Added 9.92%
117,808 $19.3 Million
Q4 2021

Feb 10, 2022
BUY
$182.74 - $227.9 $2.16 Million - $2.69 Million
11,808 Added 12.38%
107,176 $23.3 Million
Q3 2021

Nov 12, 2021
BUY
$170.18 - $198.21 $16.2 Million - $18.9 Million
95,368 New
95,368 $18.1 Million

Others Institutions Holding MEDP

# of Institutions
651
Shares Held
26.9M
Call Options Held
54.2K
Put Options Held
108K
View Full List

About Medpace Holdings, Inc.

MEDP Quotes by TradingView
  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $16.4B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email